EXTENDED PHENYTOIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Extended Phenytoin Sodium, and what generic alternatives are available?
Extended Phenytoin Sodium is a drug marketed by Amneal Pharms Ny, Ani Pharms, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Taro, Unichem, Wockhardt, and Wockhardt Usa. and is included in eleven NDAs.
The generic ingredient in EXTENDED PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Extended Phenytoin Sodium
A generic version of EXTENDED PHENYTOIN SODIUM was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for EXTENDED PHENYTOIN SODIUM
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 19 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EXTENDED PHENYTOIN SODIUM |
DailyMed Link: | EXTENDED PHENYTOIN SODIUM at DailyMed |
Recent Clinical Trials for EXTENDED PHENYTOIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hospital Israelita Albert Einstein | Phase 4 |
Industria FarmacĂȘutica Health Meds | Phase 4 |
University of Cambridge | Phase 3 |
Pharmacology for EXTENDED PHENYTOIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for EXTENDED PHENYTOIN SODIUM
US Patents and Regulatory Information for EXTENDED PHENYTOIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms Ny | EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040765-001 | Nov 12, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sun Pharm Inds | EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040731-002 | Jun 30, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Lupin Ltd | EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 211633-001 | Sep 30, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wockhardt Usa | EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040732-001 | Jan 30, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |